Entopsis' Option/Warrant Round

Entopsis raised a round of funding on January 10, 2017.

Entopsis is a privately held company developing novel biomedical products for research and clinical use, predominantly in the areas of oncology, autoimmune disorders, metabolic disorders and developin…

Articles about Entopsis' Option/Warrant Round: